Annual report [Section 13 and 15(d), not S-K Item 405]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

    2024     2023  
    For the year ended December 31,  
    2024     2023  
             
Shares of common stock issuable upon exercise of stock options     176,587       179,001  
Shares of common stock underlying restricted stock     3,320,811       2,448,169  
Shares of common stock issuable upon exercise of conversion feature of loan agreement     614,251        
Shares of common stock issuable upon exercise of warrants     9,987,560       9,397,879  
Total     14,099,209       12,025,049